Skip to content
2000
Volume 5, Issue 7
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

There is a growing amount of evidence suggesting that cannabinoids may be neuroprotective in CNS inflammatory conditions. Advances in the understanding of the physiology and pharmacology of the cannabinoid system have increased the interest of cannabinoids as potential therapeutic targets. Cannabinoid receptors and their endogenous ligands, the endocannabinoids, have been detected in cells of the immune system, as well as in brain glial cells. In the present review it is summarized the effects of cannabinoids on immune reactivity and on the regulation of neuroinflammatory processes associated with brain disorders with special attention to chronic inflammatory demyelinating diseases such as multiple sclerosis.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557054368790
2005-07-01
2025-10-10
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557054368790
Loading

  • Article Type:
    Review Article
Keyword(s): cannabinoids; glial cells; immune function; multiple sclerosis; neuroinflammation
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test